You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
38 Geriatria 2007 Vol. XIX; n. 1 <strong>Gennaio</strong>/Febbraio<br />
1. LIN S. Y., SHEU W. H., CHEN W. Y., LEE F. Y., HANG C. J.: Stimulated<br />
resistin expression in white adipose of rats with bile duct ligation-induced<br />
liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased<br />
tumor necrosis factor-alpha. Mol. Cell Endocrinol. 2005; 232: 1-8.<br />
2. SCHAFFLER A., SCHOLMERIC J., BUCHLER C.: Mechanisms of<br />
disease: adipocytokines and visceral adipose-tissue. Emerging role in<br />
nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol.<br />
2005; 2: 273-280.<br />
3. BERTOLANI C., SANCHO-BRU P., FAILLI P., BATALLER R., ALEFFI<br />
S., DEFRANCO R., MAZZINGHI B., ROMAGNANI P., DILANI S., GINES<br />
P.: Resistin as an intrahepatic cytokine:overexpression during chronic<br />
injury and Induction of proinflammatory actions in hepatic stellate cells.<br />
Am. J. Pathol. 2006; 169: 2042-2053.<br />
4. FAIN J. N.: Release of interleukins and other inflammatory cytokines by<br />
human adipose tissue is enhanced in obesity and primarily due to the<br />
nonfat cells. Vitam. Horm. 2006; 74: 443-477.<br />
5. BASTARD J. P. MAACHI M., LAGATHU C., KIM M. J., CARON M.,<br />
VIDAL H., CAPEAU J., FEVE B.: Recent advances in the relationship<br />
between obesità, inflammation, and insulin resistance. Eur. Cytokine<br />
Netw 2006; 17: 4-12.<br />
6. MODI A. A., CHUANG A. Z., ZELA S. A., ANKOMA-SEY V.<br />
:Comparison of unique clinical indicators of non-alcoholic fatty liver disease<br />
(NAFLD) in obese and non-obese (lean) patients. Hepatology 2004; 4<br />
(Suppl. 1): 586-590.<br />
7. SAMER G., ROSADO B., LINDOR K., CHARLTON M. R.: Adipokine<br />
levels are predictive of histology in patients with non-alcoholic fatty liver.<br />
Hepatology 2004; 4 (Suppl. 1): 270-277.<br />
8. FU Y., LUO L., LUO N., GARVEY W. T.: Proinflammatory cytokine production<br />
and insulin sensitività regulated by overexpression of resistin in<br />
3T3-L1 adipocy tes. Nutr. Metab. (London) 2006; 3: 28.<br />
9. BOKAREWA M., NAGAEV I., DAHLBERG L., SMITH U., TARKOSKI<br />
A.: Resistin, an adipokine with potent proinflammatory properties. J.<br />
Immunol. 2005; 174: 5789-5795.<br />
10. BARANOVA A., GOWDER S. J., SCHLAUCH K., ELARINY H., COL-<br />
LANTES R., AFENDY A., ONG J.P., GOODMAN Z., CHANDHOKE V.,<br />
YOUNOSSI Z.M.: Gene expression of leptin, resistin, and adiponectin in<br />
the whitw adipose tissue of obese patients with non-alcoholic Fatty liver<br />
disease and insuline resistance. Obes. Surg. 2006 ; 16: 1118-1125.<br />
11. MEIER U., GRESSNER A. M.: Endocrine regulation of energy metabolism:<br />
review of pathobiochemical and clinical aspects of leptin, ghrelin,<br />
BIBLIOGRAFIA<br />
adiiponectin, and resistin. Clin. Chem. 2004; 50: 1511-1525.<br />
12. LU H. L., WANG H. W., WEN Y., ZHANG M. X., LIN H. H.: Roles of<br />
adipocyte derived hormone adiponectin and resistin in insulin resistance<br />
of type 2 diabetes. World J. Gastroenterol. 2006; 12: 1747-1751.<br />
13. BAHR M. J., OCKENGA J., BOKER K. H., MANNS M. P., TIETGE U.<br />
J.: Elevated resistin levels in cirrhosis are associated with the proinflammatory<br />
state and altered hepatic glucose metabolism but not with insulin<br />
resistance. Am J. Physiol Endocrinol. Metab. 2006; 291: 199-206.<br />
14. YAGMUR E., TRAUTWEIN C., GRESSNER A., TACKE F. :Resistin<br />
serum levels are associated with insulin resistance, disease severity, clinical<br />
complication and prognosis in patients with chronic liver diseases.<br />
Am. J. Gastroenterol. 2006; 101: 1244-1252.<br />
15. PAGANO C., SOARDO G., PILON C., MILOCCO C., BASAN L., MILAN<br />
G., DONNINI D., FAGGIAN D., MUSSAP M., PLEBANI M., AVELLINI C.,<br />
FEDERSPIL G., SECHI L. A., VETTOR R.: Increased serum resistin in<br />
nonalcoholic fatty liver disease is related to liver disease severity and not to<br />
insulin resistance. J. Clin. Endocrinol. Metab. 2006; 91: 1081-1086.<br />
16. RIQUELME A., BAUDRAND R., MORALES A., PEREZ R. M., ALVA-<br />
REZ M. GONZALEZ R., HERNANDEZ V., SOZA A., ARRESE M.: Highsensitivity<br />
C-reactive protein, a new marker for non-alcoholic fatty liver<br />
disease: a population-based-study. Hepatology 2004; 4 (Suppl. 1): 584, 5.<br />
17. SANCHO-BRU P., BATALLER R., COLMENERO J., GASULL X.,<br />
MORENO M., ARROYO V., BRENNER D. A., GINES P.: Norepinephrine<br />
induces calcium spikes and proinflammatory actions in human hepatic stellate<br />
cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 291: 877-884.<br />
18. MIGITA K., MAEDA Y., ABIRU S., NAKAMURA M., KOMORI A.,<br />
YOKOYAMA T., TAKII Y., MORI T., YATSUHASHI H., EDUCHI K., ISHI-<br />
BASHI H.: Immunosuppressant FK506 inhibits matrix metalloproteinase-<br />
9 induction in TNF-alpha-stimulated human hepatic stellate cells. Life Sci<br />
2006; 78: 2510-2515.<br />
19. AXELSSON J., BERGSTEN A., QURESHI A. R., HEIMBURGER O.,<br />
BARANY P., LONNQVIST F., LINDHOLM B., NORDFORS L., ALVE-<br />
STRAND A., STEINVINKEL P.: Elevated resistin levels in chronic kidney<br />
disease are associated with decreased glomerular filtration rate and<br />
inflammation, but not with insulin resistance. Kidney In. 2006; 69: 596-604.<br />
20. FILIPPIDIS G., LIAKOPOULOS V., MERTENS P. R., KIROPOULOS<br />
T., STAKIAS N., VERIKOUKI C., PATSIDIS E., KOUKOULIS G., STEFA-<br />
NIDIS I.: Resistin serum levels are increase but not correlated with insulin<br />
resistance in chronic hemodialysis patients. Blood Purif. 2005; 23:<br />
421-428.
Change language